Ligand Pharmaceuticals Inc (LGND)
70.37
-0.63
(-0.89%)
USD |
NASDAQ |
Apr 25, 16:00
70.26
-0.11
(-0.16%)
After-Hours: 20:00
Ligand Pharmaceuticals Total Return Level: 99.54 for April 24, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 24, 2024 | 99.54 |
April 23, 2024 | 97.98 |
April 22, 2024 | 96.07 |
April 19, 2024 | 101.60 |
April 18, 2024 | 101.67 |
April 17, 2024 | 110.57 |
April 16, 2024 | 112.04 |
April 15, 2024 | 111.83 |
April 12, 2024 | 114.06 |
April 11, 2024 | 114.16 |
April 10, 2024 | 113.25 |
April 09, 2024 | 114.26 |
April 08, 2024 | 111.59 |
April 05, 2024 | 109.29 |
April 04, 2024 | 109.32 |
April 03, 2024 | 104.76 |
April 02, 2024 | 102.63 |
April 01, 2024 | 103.18 |
March 28, 2024 | 102.48 |
March 27, 2024 | 99.91 |
March 26, 2024 | 96.23 |
March 25, 2024 | 97.08 |
March 22, 2024 | 99.54 |
March 21, 2024 | 102.28 |
March 20, 2024 | 102.49 |
Date | Value |
---|---|
March 19, 2024 | 101.23 |
March 18, 2024 | 101.13 |
March 15, 2024 | 99.66 |
March 14, 2024 | 100.84 |
March 13, 2024 | 102.00 |
March 12, 2024 | 101.44 |
March 11, 2024 | 101.29 |
March 08, 2024 | 103.42 |
March 07, 2024 | 101.60 |
March 06, 2024 | 101.93 |
March 05, 2024 | 103.74 |
March 04, 2024 | 106.94 |
March 01, 2024 | 110.33 |
February 29, 2024 | 111.24 |
February 28, 2024 | 118.25 |
February 27, 2024 | 125.05 |
February 26, 2024 | 104.33 |
February 23, 2024 | 106.36 |
February 22, 2024 | 103.12 |
February 21, 2024 | 101.88 |
February 20, 2024 | 101.46 |
February 16, 2024 | 103.26 |
February 15, 2024 | 104.65 |
February 14, 2024 | 103.21 |
February 13, 2024 | 99.54 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
69.49
Minimum
Oct 27 2023
302.57
Maximum
Feb 09 2021
139.22
Average
135.86
Median
Total Return Level Benchmarks
ANI Pharmaceuticals Inc | 65.43 |
ADMA Biologics Inc | 6.44 |
Viking Therapeutics Inc | 68.86 |
Corcept Therapeutics Inc | 22.48 |
Palatin Technologies Inc | 1.73 |